We have located links that may give you full text access.
Genomic characterisation of multi-drug resistant Escherichia coli and Klebsiella pneumoniae co-harbouring mcr-1 and mcr-3 genes on a single plasmid from paediatric clinical cases.
Journal of Global Antimicrobial Resistance 2023 July 21
BACKGROUND: Emergence of plasmid-born mobile colistin resistance (mcr) gene, a growing concern in healthcare. Therefore, this study aims to genomically characterize multidrug-resistant Escherichia coli and Klebsiella pneumoniae co-harboring the mcr-1 and mcr-3 genes in young children.
METHODS: E. coli (n=3) and K. pneumoniae (n=2) were collected from abdominal secretion and blood, respectively. The isolates were screened using tryptone soya broth (TSB) with 4µl/ml polymyxin-B. Growing bacteria were identified using the VITEK-2 system, MALDI-TOF and 16s RNA sequencing, followed by antibiotic susceptibility testing, as well as metallo-β-lactamase (MBL) and extended spectrum β-lactamase (ESBL) production was detected. Afterwards, strains were subjected to molecular screening targeting mcr variants, and ESBLs/MBL encoding genes. Conjugation, PFGE, southern hybridisation, MLST, and Phylogenic group detection were performed. Plasmid-genome sequencing and bioinformatic analysis were performed.
RESULTS: E. coli named EC-19-322, 323, and 331 and K. pneumoniae isolates named KP-19-225 and 226 harboured both mcr-1 and mcr-3 genes. These strains were also found to be resistant to more than three classes of antibiotics. The conjugation experiment revealed the presence of mcr-1 and mcr-3 on the single plasmid and the transmission frequency was 10-2 to 10-3 . Both strains were found to be able to produce ESBLs and MBL. E. coli EC-19-322 and 323 were identified as an ST131(O25a:H41), SP-19-331as an ST1577 (O16:H30) and K. pneumoniae as an ST231 (K2). All E. coli strains belonged to phylogenetic group B2, and the results of PFGE supported the MLST findings.
CONCLUSION: This study, reported the co-occurrence of mcr-1 and mcr-3 genes on single plasmid in pathogenic ESBLs/MBL-producing E. coli and K. pneumoniae isolated from young children.
METHODS: E. coli (n=3) and K. pneumoniae (n=2) were collected from abdominal secretion and blood, respectively. The isolates were screened using tryptone soya broth (TSB) with 4µl/ml polymyxin-B. Growing bacteria were identified using the VITEK-2 system, MALDI-TOF and 16s RNA sequencing, followed by antibiotic susceptibility testing, as well as metallo-β-lactamase (MBL) and extended spectrum β-lactamase (ESBL) production was detected. Afterwards, strains were subjected to molecular screening targeting mcr variants, and ESBLs/MBL encoding genes. Conjugation, PFGE, southern hybridisation, MLST, and Phylogenic group detection were performed. Plasmid-genome sequencing and bioinformatic analysis were performed.
RESULTS: E. coli named EC-19-322, 323, and 331 and K. pneumoniae isolates named KP-19-225 and 226 harboured both mcr-1 and mcr-3 genes. These strains were also found to be resistant to more than three classes of antibiotics. The conjugation experiment revealed the presence of mcr-1 and mcr-3 on the single plasmid and the transmission frequency was 10-2 to 10-3 . Both strains were found to be able to produce ESBLs and MBL. E. coli EC-19-322 and 323 were identified as an ST131(O25a:H41), SP-19-331as an ST1577 (O16:H30) and K. pneumoniae as an ST231 (K2). All E. coli strains belonged to phylogenetic group B2, and the results of PFGE supported the MLST findings.
CONCLUSION: This study, reported the co-occurrence of mcr-1 and mcr-3 genes on single plasmid in pathogenic ESBLs/MBL-producing E. coli and K. pneumoniae isolated from young children.
Full text links
Related Resources
Trending Papers
Haemodynamic monitoring during noncardiac surgery: past, present, and future.Journal of Clinical Monitoring and Computing 2024 April 31
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.Circulation 2024 May 9
Obesity pharmacotherapy in older adults: a narrative review of evidence.International Journal of Obesity 2024 May 7
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app